Help Sophia Glenn Fight The Cancer - Raising funds for unfunded medication, $12,000 - $15,000 per month.

$21,820 donated
Given by 350 generous donors in around 6 months

Sophia now requires unfunded drugs for the BEACON trial, costing $12,000 to $15,000 per month.

Dunedin, Otago

Thank you to everyone who donated to Sophia’s first Give a Little page, you might recall this was to help with expenses during Sophia’s last few weeks with her husband and 3 children, such as simple living costs while her husband was looking after her and then of course her funeral. Instead of a funeral, however, alongside living costs, the funds contributed to the ongoing use of, and eventually the purchase of a Rife machine, which has been crucial in managing her tumors, allowing her to spend precious time with family.

After her diagnosis, Sophia prepared for the inevitable, planning her funeral and writing cards for her children's future milestones. Tragically, after 2weeks her bowel ruptured, leaving her with a tough choice: risky surgery or a peaceful end. She chose to fight, undergoing a successful stoma surgery, but faced inadequate hospital follow-up and support, leading to pain and frustration.

On October 23rd, Sophia underwent chemotherapy, but was readmitted on the 25th with what was initially thought to be a bowel obstruction. After 4days on a drip and a gastroscopy, we received good news: her bowel was functioning well.

However, the cancer has progressed & Sophia now needs unfunded drugs (the drugs are Dabrafenib & Cetuximab) BEACON trial, costing $12k to $15k per month. While some funds remain, they are insufficient for this life-saving treatment. We are reaching out once more for your generosity to help keep this amazing woman with us for as long as possible.

Chelsea McKellar's involvement (page creator)

Long time friend

Use of funds

Funds will be going to the unfunded BEACON trial (Dabrafenib & Cetuximab) which is $12,000-$15,000 a month

Other page links

Read more

Latest update

Change to medication   12 December 2024

We have changed from Encorafenib, Binimetinib and Cetuximab to Dabrafenib and the Cetuximab. Specialists advised that Dabrafenib is very similar to Encorafenib except it is cheaper and has more side effects. If we had of gone with Encorafenib the cost would been 1.5-2x more than the initial $80,000.

Binimetinib also costs and was an option for Sophia however some trials that tested its efficacy found there was only a very small, statistically insignificant improvement by using it as well.

You can read more from the link below...

https://www.rnz.co.nz/news/national/536416/kiwis-call-for-wider-access-of-newly-funded-cancer-drug?fbclid=IwY2xjawHHF7tleHRuA2FlbQIxMAABHQD4VZbgXyQInGxuXn-vbA_WO8rsTqlS7OUXl8SELfcKTqXm26av0usYfQ_aem_h9wwYZUiDGARLNdhPa0RuQ

Thank you all so much for your kind words and generosity!

Share this update

View and comment

Read more
Givealittle’s Generosity Report for FY2025
Givealittle’s Generosity Report for FY2025 has been released, and once again it offers a powerful snapshot of how New Zealanders show up for one another. Learn More

Latest donations

Russell and Megan x
Russell and Megan x on 28 Dec 2024
$100
Julie
Julie on 15 Dec 2024    Braving the shave
All the best
$60
Guest Donor
Guest Donor on 13 Dec 2024    Braving the shave
$20
Nicole
Nicole on 13 Dec 2024    Braving the shave
From a current cancer fighter to another xx you are not alone ❤️
Private
Guest Donor
Guest Donor on 13 Dec 2024    Braving the shave
$40

Who's involved?

Chelsea McKellar's avatar
Created by Chelsea McKellar
Sophia Glenn's avatar
Paying to a verified bank account of Sophia Glenn
Page Moderated
The page has been checked by our team to make sure it complies with our terms and conditions.

Fundraisers supporting us

Any concerns?

Report this page
This campaign started on 1 Nov 2024 and ended on 30 Apr 2025.